Development of a New Nanocarrier for Dietary Garcinol: Characterization and In Vitro Efficacy Evaluation Using Breast Cancer Stem Cells Grown in Hypoxia

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Parameters</td><td class="align_center">GA-NP</td><td class="align_center">GA-HA-NP</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Drug loading (DL, %)</td><td class="align_center">5.3</td><td class="align_center">5.02</td></tr><tr><td class="align_left">Encapsulation efficiency (EE, %)</td><td class="align_center">65.8</td><td class="align_center">60.31</td></tr><tr><td class="align_left">NP yield (%)</td><td class="align_center">41.6</td><td class="align_center">31.74</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Drug loading capacity, encapsulation efficiency, and yield of NPs.</div>

Journal of Food Quality

tab4

Table 4

Table 4: Development of a New Nanocarrier for Dietary Garcinol: Characterization and In Vitro Efficacy Evaluation Using Breast Cancer Stem Cells Grown in Hypoxia 

Table 4 | Development of a New Nanocarrier for Dietary Garcinol: Characterization and In Vitro Efficacy Evaluation Using Breast Cancer Stem Cells Grown in Hypoxia 